TABLE 3.
Potentially in‐hospital modifiable risk factors | n (%) |
---|---|
Delirium during the acute COVID‐19 hospitalization | 115 (56.7%) |
Frequency of in‐person visits from friends and family during the acute COVID‐19 hospitalization (for all patients) | |
Never | 185 (91.6%) |
Once or less than once per week | 3 (1.5%) |
2–3 times per week | 5 (2.5%) |
Daily | 9 (4.5%) |
Frequency of virtual visits from friends and family during the acute COVID‐19 hospitalization (for all patients) | |
Never | 7 (3.5%) |
Once or less than once per week | 7 (3.5%) |
2–3 times per week | 16 (7.9%) |
4–5 times per week | 4 (2.0%) |
Daily | 62 (30.7%) |
Multiple times per day | 106 (52.5%) |
In‐hospital COVID‐19 treatment | |
Hydroxychloroquine | 97 (47.8%) |
Corticosteroids | 29 (14.3%) |
Remdesivir | 45 (22.2%) |